文献速递脑血管病神经重症与神经感染

急性卒中院前及到院早期神经功能恶化的频率、预测因素与结局:FAST-MAG随机临床试验的探索性分析

Frequency, Predictors, and Outcomes of Prehospital and Early Postarrival Neurological Deterioration in Acute Stroke: Exploratory Analysis of the FAST-MAG Randomized Clinical Trial.
PubMed 文献 · JAMA Neurol · 2018-01-01

该研究为FAST-MAG随机临床试验的探索性分析,纳入2005至2013年南加州315辆救护车和60家卒中接诊医院连续转运的1690例疑似急性卒中患者。结果显示,超早期神经功能恶化(U-END)发生率为11.8%,颅内出血组高于急性脑缺血组(30.8% vs 6.1%,P < .001),并与3个月功能独立性降低和死亡率升高相关。

要点

  • U-END发生于11.8%的急性脑血管病患者,颅内出血组为30.8%,急性脑缺血组为6.1%。
  • U-END与3个月功能独立性降低(16.0% vs 56.6%)和死亡率升高(43.5% vs 11.8%)相关。
  • 避免U-END可能是未来院前治疗的目标。

核心结论

  • 超早期神经功能恶化发生于1/8的救护车转运急性脑血管病患者,包括1/3的颅内出血患者和1/16的急性脑缺血患者,并与功能独立性显著降低和死亡率升高相关。
  • 作者认为,避免U-END可能是未来院前治疗的目标。

研究设计与样本

  • FAST-MAG随机临床试验的探索性分析,于2005至2013年在南加州315辆救护车和60家卒中接诊医院开展。
  • 连续纳入卒中发作2小时内由救护车转运的疑似急性卒中患者1690例(99.4%),平均(SD)年龄69.4(13.5)岁,43%为女性。
  • 最终诊断:急性脑缺血1237例(73.2%),颅内出血386例(22.8%),神经血管模拟症67例(4.0%)。
  • 主要结局为神经功能恶化,定义为格拉斯哥昏迷量表(GCS)评分恶化≥2分;GCS范围3-15分,评分越高表示越警觉。

主要发现

  • 从院前至到院早期,U-END发生于1690例中的200例(11.8%),颅内出血组高于急性脑缺血组(119/386 [30.8%] vs 75/1237 [6.1%],P < .001)。
  • U-END模式:院前U-END无早期恢复30/965(3.1%),院前稳定但急诊早期恶化49/965(5.1%),院前及急诊早期持续恶化27/965(2.8%)。
  • U-END与3个月结局相关:全球残疾mRS评分4.6 vs 2.4(P < .001);功能独立(mRS 0-2)32/200(16.0%) vs 844/1490(56.6%)(P < .001);死亡87/200(43.5%) vs 176/1490(11.8%)(P < .001)。
  • 末次正常时间至GCS评估的中位(IQR)分钟数:院前23(14-42)分钟,急诊到达58(46-79)分钟,急诊早期149(120-180)分钟。

关键数值与推荐

  • 神经功能恶化定义:GCS评分恶化≥2分。
  • 影像学结局:首次脑影像扫描发现的缺血性或出血性损伤范围。
  • 3个月结局包括全球残疾水平(改良Rankin量表[mRS];范围0-6,评分越高残疾越重)和死亡率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Studies of neurological deterioration in stroke have focused on the subacute period, but stroke treatment is increasingly migrating to the prehospital setting, where the neurological course has not been well delineated. OBJECTIVE: To describe the frequency, predictors, and outcomes of neurological deterioration among patients in the ultra-early period following ischemic stroke or intracranial hemorrhage. DESIGN, SETTINGS, AND PARTICIPANTS: Exploratory analysis of the prehospital, randomized Field Administration of Stroke Therapy-Magnesium (FAST-MAG) Trial conducted from 2005 to 2013 within 315 ambulances and 60 stroke patient receiving hospitals in Southern California. Participants were consecutively enrolled patients with suspected acute stroke who were transported by ambulance within 2 hours of stroke onset. MAIN OUTCOMES AND MEASURES: The main outcome was neurological deterioration, defined as a worsening of 2 or more points on the Glasgow Coma Scale (GCS), a level of consciousness scale ranging from 3 to 15, with higher scores indicating more alertness. Imaging outcomes were ischemic or hemorrhagic injury extent identified during the first brain imaging scan. Outcomes at 3 months included global disability level (assessed using the modified Rankin Scale [mRS]; range, 0-6, with higher numbers indicating greater disability) and mortality. RESULTS: Among the 1690 patients (99.4%), the mean (SD) age was 69.4 (13.5) years, and 43% were female. Final diagnoses were acute cerebral ischemia in 1237 patients (73.2%), intracranial hemorrhage in 386 patients (22.8%), and neurovascular mimic in 67 patients (4.0%). The median (interquartile range [IQR]) minutes between the last well-known time and GCS assessments were 23 (14-42) minutes for prehospital, 58 (46-79) minutes for ED arrival, and 149 (120-180) minutes for early ED course assessments. From prehospital to early postarrival, ultra-early neurological deterioration (U-END) occurred in 200 of 1690 patients (11.8%), more often among patients with intracranial hemorrhage than among those with acute cerebral ischemia (119 of 386 [30.8%] vs 75 of 1237 [6.1%], P < .001). Patterns of U-END were prehospital U-END without early recovery in 30 of 965 patients (3.1%), stable prehospital course but early ED deterioration in 49 of 965 patients (5.1%), and continuous deterioration in both prehospital and early ED phases in 27 of 965 patients (2.8%). Ultra-early neurological deterioration was associated with worse 3-month outcomes, including increased global disability (mRS score, 4.6 vs 2.4; P < .001), reduced functional independence (mRS score 0-2, 32 of 200 [16.0%] vs 844 of 1490 [56.6%]; P < .001), and increased mortality (87 of 200 [43.5%] vs 176 of 1490 [11.8%]; P < .001). CONCLUSIONS AND RELEVANCE: Ultra-early neurological deterioration occurs in 1 in 8 ambulance-transported patients with acute cerebrovascular disease, including 1 in 3 patients with intracranial hemorrhage and 1 in 16 patients with acute cerebral ischemia, and is associated with markedly reduced functional independence and increased mortality. Averting U-END may be a target for future prehospital therapeutics. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00059332.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Shkirkova K, Saver JL, Starkman S, et al. Frequency, Predictors, and Outcomes of Prehospital and Early Postarrival Neurological Deterioration in Acute Stroke: Exploratory Analysis of the FAST-MAG Randomized Clinical Trial. JAMA Neurol. 2018. PMID: 30039165. doi:10.1001/jamaneurol.2018.1893

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。